Alvaro Torres

Khiron Snatches First Medical Cannabis Contract With One Of Colombia's Largest Insurance Companies
Khiron Q3 Revenue Declines 24% Sequentially To $2.5M
Khiron Q2 Revenue Grows 60% YoY, Despite Decline In Medical Cannabis Sales In Germany
Khiron Q3 Revenue Declines 24% Sequentially To $2.5M
Khiron Q2 Revenue Grows 60% YoY, Despite Decline In Medical Cannabis Sales In Germany
These 9 Cannabis Companies Are Leading The Way In Latin America: What Are They Up To And Why Should You Pay Attention?
Five Latinxs To Watch In The Cannabis Space: Meet The Who's Who At Benzinga's Cannabis Capital Conference In Chicago

Alvaro Torres Recent News

Khiron Reveals Results Of 2022 Annual General And Special Meeting
Khiron Life Sciences Corp. (OTCQX: KHRNF) (TSXV:KHRN) (Frankfurt: A2JMZC), a global leader in medical cannabis throughout Latin America and Europe, revealed the results of its 2022 annual general and special meeting of shareholders held on June 23, 2022.
Khiron Life Sciences Q1 2022 Financial Results Show Record Revenue In Medical Cannabis
Khiron Life Sciences Corp. (OTCQX: KHRNF) (TSXV: KHRN) (Frankfurt: A2JMZC) released its financial results for the quarter ended March 31, 2022, revealing record revenue in the medical cannabis business.
Cannabis Dispensary Roundup: Where To Buy Rec Marijuana In New Jersey, CBD Spas & More Store Openings
Khiron Opens New Zerenia Clinic And Medical Cannabis Pharmacy In Colombia
How Efficient Is Medicinal Cannabis As Treatment For Chronic Pain? Khiron's Clinical Study Reveals
EXCLUSIVE: Medical Cannabis Innovator Khiron Partners With Health Care Company Teleton In Mexico
Khiron Adds Another Clinic Location In Peru In Partnership With Pain Clinic CDL
Medical marijuana company Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) is opening another Zerenia location in Peru in partnership with the renowned pain clinic, CDL. Khiron In Peru Highlights
Cannabis Dispensary Roundup: Cresco Labs, High Tide, Khiron, Cordova Cann
Cresco Labs Opens 14th Florida Medical Cannabis Dispensary
Khiron Life Sciences Q3 Revenue Grows 83% YoY To $2.78M
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) announced its financial results on Monday for the quarter ended September 30, 2021 reporting revenues of CA$3.52 million ($2.78 million), compared to CA$1.93 million in the same period year ago.
Khiron Life Sciences' Study: 80% Positively Respond To Cannabinoid Treatment For Chronic Pain And Other Conditions
A vertically integrated cannabis company Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) announced Wednesday results from its first research study including 1,453 patients from Khiron-owned Zerenia Clinics.
Khiron Life Sciences Reveals 47% QoQ Spike In Medical Revenue, Q2 2021 Cannabis Revenue Increases 68% YoY
Vertically integrated cannabis company Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) announced its latest financial results Monday, revealing a 68% year-over-year jump in revenue to CA$2.8 million (CA$2.18 million) in the second quarter of 2021. Shares trad
Cannabis Movers & Shakers: Khiron, Aleafia, Green Scientific Labs, 4Front Ventures, Halo Collective, Kiva Sales & Service, Sharp Capital Advisors, Simplifya, Organigram
Khiron Appoints Dr. Eduardo Faveret As Medical Director For Zerenia Brazil
Khiron Cannabis Co To Debut South Of The Border, Obtains High-THC Extract Export Quotas For Mexico
Vertically integrated cannabis company Khiron Life Sciences Corp. (TSXV: KHRN)  (OTCQX: KHRNF) received a quota to export over 700 kg of high-THC extract to Mexico.
How COVID-19 Is Affecting Cannabis Companies in Colombia
As cannabis businesses in North America attempt to navigate the imminent recession, Colombia’s largest cannabis operators are sharing comments of tranquility in the midst of global market turmoil.
The Cannabis Industry's Go-Public Frenzy: A Chat With Companies That IPOed This Year
Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week